Results 111 to 120 of about 2,272,612 (281)
The increasing deployment of agentic artificial intelligence (AI) systems and decentralized digital infrastructures has challenged traditional assumptions about organizational administration, control, and governance.
Aravindh Sekar
doaj +1 more source
Local AI Governance: Addressing Model Safety and Policy Challenges Posed by Decentralized AI
Policies and technical safeguards for artificial intelligence (AI) governance have implicitly assumed that AI systems will continue to operate via massive power-hungry data centers operated by large companies like Google and OpenAI.
Bahrad A. Sokhansanj
core +1 more source
ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source
This study examines the sovereignty-internationalism paradox in AI governance, which encapsulates the tension between state control over algorithmic systems and the necessity of transnational collaboration to regulate borderless technologies.
Artur Ishkhanyan
doaj +1 more source
Saudi Arabia has established a comprehensive national-level governance landscape for generative artificial intelligence through the Saudi Data and Artificial Intelligence Authority (SDAIA), including the AI Ethics Principles (2023), Generative AI ...
Fouad Ahmed Atallah
doaj +1 more source
The Oxford handbook of AI governance /
"Book abstract: The Oxford Handbook of AI Governance examines how artificial intelligence (AI) interacts with and influences governance systems. It also examines how governance systems influence and interact with AI.
Bullock, Justin B.,
core
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source
Evaluating Trustworthiness in AI: Risks, Metrics, and Applications Across Industries
Ensuring the trustworthiness of artificial intelligence (AI) systems is critical as they become increasingly integrated into domains like healthcare, finance, and public administration.
Aleksandra Nastoska +7 more
core +1 more source
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali +4 more
wiley +1 more source
Scaling enterprise AI in healthcare: the role of governance in risk mitigation frameworks
This perspective article examines the role of governance frameworks in mitigating risks and building trust in AI implementations within healthcare organizations.
Andreea Bodnari, John Travis
doaj +1 more source

